{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "9306fd05-ce3f-4a60-8dfb-889d98bf90ed",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "1ef050e6-65a3-4e40-a3a9-60aa59eadbd6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "68433cb4-39a6-4ff6-a3e7-d2403e62961e",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "bc48da1a-3486-4dc5-83ab-4b7c16f7da55",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon (IMG) used as an active comparator.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human Regular Insulin",
        "type": {
          "id": "cbd55c2b-e7c1-4b63-9bad-f8ba00ad394b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6a34b144-07d1-4642-b809-1f7167d5bf24",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "IV Glucose",
        "type": {
          "id": "00f3e341-ef91-445c-9d8f-45efafd52ae1",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "836f5755-06c1-4a67-9a4e-29b17c62c14f",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if a patient's plasma glucose remains too low after glucagon administration or if severe hypoglycemia symptoms occur.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "b2866780-a7ee-4d7e-a2f9-3d885e2c5cfa",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "39cc05c3-ec59-4a87-a6bc-cd59861d76b4",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c8711059-9c71-4f62-8da4-e3809708a1e1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Lilly"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "9557b43e-0748-4e5a-b524-f00da15cf623",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "5982b70d-345f-4937-b4a5-bcd23240121e",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e0cf9a51-0e0e-470f-9b5e-6aa77df1eba0",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human Regular Insulin",
        "administrableDoseForm": {
          "id": "8d8d3e59-28ac-4de9-ad17-e32e661ac734",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "9be90aef-e5d3-4310-ae92-7020882a9a1e",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "6110ea98-e97a-474d-93bc-5686b995d92c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0.3 U/mL",
        "substanceIds": [
          "sub_3"
        ]
      },
      {
        "id": "prod_4",
        "name": "IV Glucose",
        "administrableDoseForm": {
          "id": "a1d892f9-7bbf-43c1-8189-ab0cffcc2f72",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "62362837-6e07-45c4-81cb-e5e13cb25889",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8b028e81-44af-4c0f-9c7e-af52aafa8224",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 3 mg single dose",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "single dose",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen 1 mg single dose",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "id": "admin_3",
        "name": "Human Regular Insulin infusion",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "doseFrequency": "continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until plasma glucose is <60 mg/dL"
      },
      {
        "id": "admin_4",
        "name": "IV Glucose rescue",
        "instanceType": "Administration",
        "dose": "Not specified",
        "doseFrequency": "as needed",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Administered if patient's bedside PG concentration remains <55 mg/dL at 30 minutes or <60 mg/dL at 45 minutes postdose, or as deemed clinically necessary."
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Glucagon",
        "instanceType": "Substance",
        "description": "A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "Human Regular Insulin",
        "instanceType": "Substance",
        "description": "Used to induce hypoglycemia."
      },
      {
        "id": "sub_3",
        "name": "Glucose",
        "instanceType": "Substance",
        "description": "Used as rescue therapy for insufficient response to glucagon."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal delivery device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Lilly"
      }
    ],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon (IMG) used as an active comparator."
      },
      {
        "name": "Human Regular Insulin",
        "role": "Concomitant Medication",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure."
      },
      {
        "name": "IV Glucose",
        "role": "Rescue Medication",
        "description": "Administered if a patient's plasma glucose remains too low after glucagon administration or if severe hypoglycemia symptoms occur."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Nasal powder",
        "strength": "3 mg",
        "manufacturer": "Lilly"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Powder for injection",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human Regular Insulin",
        "doseForm": "Solution for infusion",
        "strength": "0.3 U/mL",
        "manufacturer": null
      },
      {
        "name": "IV Glucose",
        "doseForm": "Solution for infusion",
        "strength": null,
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "Glucagon",
        "description": "A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "Human Regular Insulin",
        "description": "Used to induce hypoglycemia."
      },
      {
        "name": "Glucose",
        "description": "Used as rescue therapy for insufficient response to glucagon."
      }
    ],
    "administrations": [
      {
        "name": "LY900018 3 mg single dose",
        "dose": "3 mg",
        "frequency": "single dose",
        "route": "Intranasal",
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "name": "GlucaGen 1 mg single dose",
        "dose": "1 mg",
        "frequency": "single dose",
        "route": "Intramuscular",
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "name": "Human Regular Insulin infusion",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "frequency": "continuous infusion",
        "route": "Intravenous",
        "duration": "Until plasma glucose is <60 mg/dL"
      },
      {
        "name": "IV Glucose rescue",
        "dose": "Not specified",
        "frequency": "as needed",
        "route": "Intravenous",
        "duration": "Administered if patient's bedside PG concentration remains <55 mg/dL at 30 minutes or <60 mg/dL at 45 minutes postdose, or as deemed clinically necessary."
      }
    ],
    "devices": [
      {
        "name": "Nasal delivery device",
        "manufacturer": "Lilly",
        "purpose": "A single-use device, included as part of the LY900018 investigational drug product, used to deliver the glucagon powder into the nasal cavity."
      }
    ]
  }
}